377 related articles for article (PubMed ID: 18985997)
1. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.
Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG
Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997
[TBL] [Abstract][Full Text] [Related]
2. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
[TBL] [Abstract][Full Text] [Related]
3. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.
Davison SN; Jhangri GS; Jindal K; Pannu N
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1044-50. PubMed ID: 19406971
[TBL] [Abstract][Full Text] [Related]
4. Icodextrin Simplifies PD Therapy by Equalizing UF and Sodium Removal Among Patient Transport Types During Long Dwells: A Modeling Study.
Akonur A; Sloand J; Davis I; Leypoldt J
Perit Dial Int; 2016; 36(1):79-84. PubMed ID: 25185017
[TBL] [Abstract][Full Text] [Related]
5. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
[TBL] [Abstract][Full Text] [Related]
6. Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.
Akonur A; Firanek CA; Gellens ME; Hutchcraft AM; Kathuria P; Sloand JA
Perit Dial Int; 2016; 36(2):188-95. PubMed ID: 26293841
[TBL] [Abstract][Full Text] [Related]
7. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis.
Rodríguez-Carmona A; Fontán MP
Perit Dial Int; 2002; 22(6):705-13. PubMed ID: 12556073
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
10. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Peritoneal Low-Molecular-Weight-Protein-Removal in CCPD and CAPD Patients Based on C-Terminal Agrin Fragment Clearance.
Steubl D; Roos M; Hettwer S; Angermann S; Wen M; Schmaderer C; Luppa P; Heemann U; Renders L
Kidney Blood Press Res; 2016; 41(2):175-85. PubMed ID: 26959245
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sodium removal in peritoneal dialysis patients treated by continuous ambulatory and automated peritoneal dialysis.
Maharjan SRS; Davenport A
J Nephrol; 2019 Dec; 32(6):1011-1019. PubMed ID: 31502219
[TBL] [Abstract][Full Text] [Related]
13. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
Akonur A; Guest S; Sloand JA; Leypoldt JK
Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.
Ortega O; Gallar P; Carreño A; Gutierrez M; Rodriguez I; Oliet A; Vigil A; Gimenez E
Am J Nephrol; 2001; 21(3):189-93. PubMed ID: 11423687
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.
Wolfson M; Piraino B; Hamburger RJ; Morton AR;
Am J Kidney Dis; 2002 Nov; 40(5):1055-65. PubMed ID: 12407652
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
[TBL] [Abstract][Full Text] [Related]
17. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2005; 21():21-4. PubMed ID: 16686279
[TBL] [Abstract][Full Text] [Related]
18. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
[TBL] [Abstract][Full Text] [Related]
19. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
[TBL] [Abstract][Full Text] [Related]
20. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
